These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
741 related items for PubMed ID: 23707765
1. Wogonin inhibits tumor angiogenesis via degradation of HIF-1α protein. Song X, Yao J, Wang F, Zhou M, Zhou Y, Wang H, Wei L, Zhao L, Li Z, Lu N, Guo Q. Toxicol Appl Pharmacol; 2013 Sep 01; 271(2):144-55. PubMed ID: 23707765 [Abstract] [Full Text] [Related]
2. Rhapontigenin inhibited hypoxia inducible factor 1 alpha accumulation and angiogenesis in hypoxic PC-3 prostate cancer cells. Jung DB, Lee HJ, Jeong SJ, Lee HJ, Lee EO, Kim YC, Ahn KS, Chen CY, Kim SH. Biol Pharm Bull; 2011 Sep 01; 34(6):850-5. PubMed ID: 21628883 [Abstract] [Full Text] [Related]
3. Wogonin inhibits multiple myeloma-stimulated angiogenesis via c-Myc/VHL/HIF-1α signaling axis. Fu R, Chen Y, Wang XP, An T, Tao L, Zhou YX, Huang YJ, Chen BA, Li ZY, You QD, Guo QL, Wu ZQ. Oncotarget; 2016 Feb 02; 7(5):5715-27. PubMed ID: 26735336 [Abstract] [Full Text] [Related]
4. Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibition. Chintala S, Najrana T, Toth K, Cao S, Durrani FA, Pili R, Rustum YM. BMC Cancer; 2012 Jul 17; 12():293. PubMed ID: 22804960 [Abstract] [Full Text] [Related]
5. Gambogic acid inhibits angiogenesis through inhibiting PHD2-VHL-HIF-1α pathway. Lu N, Hui H, Yang H, Zhao K, Chen Y, You QD, Guo QL. Eur J Pharm Sci; 2013 May 13; 49(2):220-6. PubMed ID: 23501055 [Abstract] [Full Text] [Related]
7. RACK1 competes with HSP90 for binding to HIF-1alpha and is required for O(2)-independent and HSP90 inhibitor-induced degradation of HIF-1alpha. Liu YV, Baek JH, Zhang H, Diez R, Cole RN, Semenza GL. Mol Cell; 2007 Jan 26; 25(2):207-17. PubMed ID: 17244529 [Abstract] [Full Text] [Related]
8. Hypoxia-inducible factor 1alpha and antiangiogenic activity of farnesyltransferase inhibitor SCH66336 in human aerodigestive tract cancer. Han JY, Oh SH, Morgillo F, Myers JN, Kim E, Hong WK, Lee HY. J Natl Cancer Inst; 2005 Sep 07; 97(17):1272-86. PubMed ID: 16145048 [Abstract] [Full Text] [Related]
9. Minocycline accelerates hypoxia-inducible factor-1 alpha degradation and inhibits hypoxia-induced neovasculogenesis through prolyl hydroxylase, von Hippel-Lindau-dependent pathway. Li CH, Liao PL, Yang YT, Huang SH, Lin CH, Cheng YW, Kang JJ. Arch Toxicol; 2014 Mar 07; 88(3):659-71. PubMed ID: 24292262 [Abstract] [Full Text] [Related]
10. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells. Chen MC, Lee CF, Huang WH, Chou TC. Biochem Pharmacol; 2013 May 01; 85(9):1278-87. PubMed ID: 23416116 [Abstract] [Full Text] [Related]
11. Minoxidil Induction of VEGF Is Mediated by Inhibition of HIF-Prolyl Hydroxylase. Yum S, Jeong S, Kim D, Lee S, Kim W, Yoo JW, Kim JA, Kwon OS, Kim DD, Min DS, Jung Y. Int J Mol Sci; 2017 Dec 25; 19(1):. PubMed ID: 29295567 [Abstract] [Full Text] [Related]
13. Inhibition of heat shock protein 90 impairs epidermal growth factor-mediated signaling in gastric cancer cells and reduces tumor growth and vascularization in vivo. Lang SA, Klein D, Moser C, Gaumann A, Glockzin G, Dahlke MH, Dietmaier W, Bolder U, Schlitt HJ, Geissler EK, Stoeltzing O. Mol Cancer Ther; 2007 Mar 14; 6(3):1123-32. PubMed ID: 17363505 [Abstract] [Full Text] [Related]
14. Wogonin influences vascular permeability via Wnt/β-catenin pathway. Song X, Zhou Y, Zhou M, Huang Y, Li Z, You Q, Lu N, Guo Q. Mol Carcinog; 2015 Jul 14; 54(7):501-12. PubMed ID: 24136474 [Abstract] [Full Text] [Related]
16. C-Terminal HSP90 Inhibitors Block the HIF-1 Hypoxic Response by Degrading HIF-1α through the Oxygen-Dependent Degradation Pathway. Kataria N, Martinez CA, Kerr B, Zaiter SS, Morgan M, McAlpine SR, Cook KM. Cell Physiol Biochem; 2019 Feb 02; 53(3):480-495. PubMed ID: 31486323 [Abstract] [Full Text] [Related]
17. Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases. Marxsen JH, Stengel P, Doege K, Heikkinen P, Jokilehto T, Wagner T, Jelkmann W, Jaakkola P, Metzen E. Biochem J; 2004 Aug 01; 381(Pt 3):761-7. PubMed ID: 15104534 [Abstract] [Full Text] [Related]
18. LW6, a novel HIF-1 inhibitor, promotes proteasomal degradation of HIF-1alpha via upregulation of VHL in a colon cancer cell line. Lee K, Kang JE, Park SK, Jin Y, Chung KS, Kim HM, Lee K, Kang MR, Lee MK, Song KB, Yang EG, Lee JJ, Won M. Biochem Pharmacol; 2010 Oct 01; 80(7):982-9. PubMed ID: 20599784 [Abstract] [Full Text] [Related]
19. Effect of connective tissue growth factor on hypoxia-inducible factor 1alpha degradation and tumor angiogenesis. Chang CC, Lin MT, Lin BR, Jeng YM, Chen ST, Chu CY, Chen RJ, Chang KJ, Yang PC, Kuo ML. J Natl Cancer Inst; 2006 Jul 19; 98(14):984-95. PubMed ID: 16849681 [Abstract] [Full Text] [Related]
20. Runx2 protein stabilizes hypoxia-inducible factor-1α through competition with von Hippel-Lindau protein (pVHL) and stimulates angiogenesis in growth plate hypertrophic chondrocytes. Lee SH, Che X, Jeong JH, Choi JY, Lee YJ, Lee YH, Bae SC, Lee YM. J Biol Chem; 2012 Apr 27; 287(18):14760-71. PubMed ID: 22351759 [Abstract] [Full Text] [Related] Page: [Next] [New Search]